September 29 Summit Offers Complimentary Registration for All
The ISPOR-FDA Summit 2020 on Patient-Preference Information in Medical Devices is now virtual. Our expert researchers will be speaking at the following sessions during the Summit on September 29, 2020
Session 1: Introduction to and Background of Patient-Preference Information (PPI)
10:45-11:30 am ET
This session will provide an overview of PPI and the various terms referenced in this field. This will include a discussion on the fundamentals of how PPI differs from other types of patient-provided information and the different types of regulatory decisions that can be informed by PPI. A review of current regulatory documents that involve PPI, as well as an explanation of the quality measures considered by CDRH will be presented.
Speakers: Anindita (Annie) Saha, Brett Hauber, PhD
Session 2: Case Studies for Use of PPI in Medical Device Decision-Making Processes
11:30 am - 1:00 pm ET
This session will be comprised of 4 separate case study presentations involving PPI. The cases will offer insights into the reason or indication for the PPI study, problems/challenges that were successfully addressed or unsuccessfully resolved, and a summary of the overall outcomes and lessons learned. Time for audience Q/A will follow at the end of the session.
Speakers: Dan Harfe; Barry Liden; Christine Poulos, PhD; Todd Snell, MBA; Kimberly Brown-Smith, PhD, MD; Michelle Tarver, MD, PhD
Registration for the Summit is complimentary. Prior registrants (for the previously scheduled event on March 31) do need to re-register for the new, completely virtual event now scheduled for September 29.
A pre-event webinar co-presented by Brett Hauber, “Patient-Preference Information—What It Is and What It Is Not,” is currently available on demand and provides a primer on the topic of patient-preference information. The webinar is recommended for Summit participants, is complimentary, and is available to be viewed by all (both registrants and non-registrants).
For additional details, including the program schedule and speaker information, please visit the ISPOR-FDA Summit 2020 website here.